It's normal, even expected, for you to have questions before starting treatment. Click below to see answers to the most commonly asked questions about FYARRO. Consult with your doctor to make sure that this guidance meets the needs of your individual treatment journey.
It's normal, even expected, for you to have questions before starting treatment. Click below to see answers to the most commonly asked questions about FYARRO. Consult with your doctor to make sure that this guidance meets the needs of your individual treatment journey.
While there is no set diet or exercise plan for people living with advanced malignant PEComa, there may be things you can do to maintain a healthy lifestyle during your treatment. Talk to your doctor about nutrition and exercise advice. Your treatment center may have a nutritionist on staff whom you can work with.
Some people may find it helpful to stay active during treatment. Discuss with your doctor how you are feeling so that, together, you can come up with an exercise routine that is best suited for you.
Avoid grapefruit and grapefruit juice while taking FYARRO. Talk to your doctor about any herbal supplements that you currently take or are considering taking as they may interact with FYARRO treatment.
Each FYARRO treatment cycle is 3 weeks, which means treatment cycles repeat every 21 days. Doses are given once a week for 2 weeks, on Day 1 and Day 8, followed by 1 week off.
While there are no data on how FYARRO impacts fertility, based on studies in animals and the way FYARRO works, male and female fertility may be affected by treatment with FYARRO. Talk to your doctor if you have specific concerns about fertility.
Certain medications, vitamins, and herbal supplements may interact with FYARRO treatment. Make sure to tell your doctor about all the medications (prescription and over the counter), vitamins, and herbal supplements that you are currently taking before starting FYARRO and they can let you know which ones you can and cannot take during treatment with FYARRO.
You should not receive a live vaccine or be around people who have recently received a live vaccine during your treatment with FYARRO. If you are not sure about the type of vaccine, ask your doctor. Vaccinations may be less effective while being treated with FYARRO.
There are organizations created for people living with cancer, including PEComa:
AadiAssist provides support services for patients taking FYARRO. Learn more about AadiAssist here.
*FYARRO is not for everyone. Talk to your doctor to see if FYARRO may be right for you.
FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat adults with malignant perivascular epithelioid cell tumors (PEComa) that have spread to other parts of the body (metastatic) or cannot be removed by surgery (locally advanced, unresectable). It is not known if FYARRO is safe and effective in people with severe liver problems or in children.
Do not use FYARRO if you have had a severe allergic reaction to sirolimus or other medications that work similarly to sirolimus (eg, everolimus, temsirolimus), or human albumin.
FYARRO can cause the following serious side effects; depending on the severity, your doctor may decide to decrease your dose or stop treatment with FYARRO:
Before taking FYARRO, tell your doctor if you are breast feeding. It is not known if FYARRO could pass into breast milk and harm your baby. You should not breast feed during treatment with FYARRO and for 2 weeks after the last dose. Tell your doctor about all your medical conditions and the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Using FYARRO with certain other medicines can cause serious side effects. Tell your doctor before you start taking any new medicine. You should not drink grapefruit juice or eat grapefruit during your treatment with FYARRO. It may make the amount of FYARRO in your blood increase to a harmful level.
The most common side effects with FYARRO include the following: mouth ulcers or sores; feeling weak or tired; rash; infection; nausea; swelling of arms, hands, feet, ankles, face, or other parts of the body; diarrhea; body pain; decreased weight and appetite; cough; vomiting; and altered taste.
These are not all the possible side effects of FYARRO. Tell your doctor if you have any side effect that bothers you or does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see full Prescribing Information.
FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat adults with malignant perivascular epithelioid cell tumors (PEComa) that have spread to other parts of the body (metastatic) or cannot be removed by surgery (locally advanced, unresectable). It is not known if FYARRO is safe and effective in people with severe liver problems or in children.
Do not use FYARRO if you have had a severe allergic reaction to sirolimus or other medications that work similarly to sirolimus (eg, everolimus, temsirolimus), or human albumin.
FYARRO can cause the following serious side effects; depending on the severity, your doctor may decide to decrease your dose or stop treatment with FYARRO:
Before taking FYARRO, tell your doctor if you are breast feeding. It is not known if FYARRO could pass into breast milk and harm your baby. You should not breast feed during treatment with FYARRO and for 2 weeks after the last dose. Tell your doctor about all your medical conditions and the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Using FYARRO with certain other medicines can cause serious side effects. Tell your doctor before you start taking any new medicine. You should not drink grapefruit juice or eat grapefruit during your treatment with FYARRO. It may make the amount of FYARRO in your blood increase to a harmful level.
The most common side effects with FYARRO include the following: mouth ulcers or sores; feeling weak or tired; rash; infection; nausea; swelling of arms, hands, feet, ankles, face, or other parts of the body; diarrhea; body pain; decreased weight and appetite; cough; vomiting; and altered taste.
These are not all the possible side effects of FYARRO. Tell your doctor if you have any side effect that bothers you or does not go away. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is a prescription medicine used to treat adults with malignant perivascular epithelioid cell tumors (PEComa) that have spread to other parts of the body (metastatic) or cannot be removed by surgery (locally advanced, unresectable). It is not known if FYARRO is safe and effective in people with severe liver problems or in children.